Guy Aumais

3.2k total citations
11 papers, 146 citations indexed

About

Guy Aumais is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Guy Aumais has authored 11 papers receiving a total of 146 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Guy Aumais's work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers) and Gastrointestinal motility and disorders (3 papers). Guy Aumais is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers) and Gastrointestinal motility and disorders (3 papers). Guy Aumais collaborates with scholars based in Canada, Belgium and United States. Guy Aumais's co-authors include Mark S. Silverberg, Remo Panaccione, Steven R. Brant, Ramnik J. Xavier, Colette Deslandres, Richard H. Duerr, Aylwin Ng, Anna Latiano, Christine Lefebvre and Vito Annese and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Guy Aumais

11 papers receiving 140 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Aumais Canada 6 66 57 41 29 26 11 146
Ana Isabel Cordeiro Portugal 6 32 0.5× 70 1.2× 28 0.7× 45 1.6× 32 1.2× 22 166
C. Pélatan France 7 38 0.6× 23 0.4× 53 1.3× 31 1.1× 30 1.2× 11 135
Savaş Kansoy Türkiye 10 50 0.8× 43 0.8× 48 1.2× 20 0.7× 20 0.8× 18 219
Peter Uebel United Kingdom 6 146 2.2× 85 1.5× 71 1.7× 79 2.7× 50 1.9× 8 259
Hilbert S. de Vries Netherlands 8 55 0.8× 35 0.6× 44 1.1× 91 3.1× 42 1.6× 11 224
Sarah O’Donnell Ireland 10 103 1.6× 50 0.9× 97 2.4× 114 3.9× 27 1.0× 28 257
Laura Loy Italy 8 106 1.6× 49 0.9× 68 1.7× 41 1.4× 22 0.8× 22 166
Alexandros Skamnelos Greece 7 91 1.4× 24 0.4× 67 1.6× 54 1.9× 16 0.6× 16 154
Shaohong Yang United States 8 73 1.1× 49 0.9× 43 1.0× 26 0.9× 34 1.3× 16 174
Joo Young Jang South Korea 7 83 1.3× 24 0.4× 55 1.3× 104 3.6× 14 0.5× 14 192

Countries citing papers authored by Guy Aumais

Since Specialization
Citations

This map shows the geographic impact of Guy Aumais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Aumais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Aumais more than expected).

Fields of papers citing papers by Guy Aumais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Aumais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Aumais. The network helps show where Guy Aumais may publish in the future.

Co-authorship network of co-authors of Guy Aumais

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Aumais. A scholar is included among the top collaborators of Guy Aumais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Aumais. Guy Aumais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bhinder, Ganive, et al.. (2023). Irritable Bowel Syndrome Patient Experience: A Survey of Patient-Reported Symptoms by Irritable Bowel Syndrome Subtype and Impact on Quality of Life. Journal of the Canadian Association of Gastroenterology. 6(6). 219–228. 4 indexed citations
3.
Turpin, Williams, Larbi Bedrani, Osvaldo Espin‐Garcia, et al.. (2018). FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects. Gut Microbes. 9(4). 1–12. 37 indexed citations
4.
Ward, Alexandra, Fernando Camacho, Elham Rahme, et al.. (2017). Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulation. Journal of Medical Economics. 21(1). 27–37. 2 indexed citations
5.
Bressler, Brian, et al.. (2016). Su1012 Canadian Patient and Caregiver Perspectives on Subsequent Entry Biologics/Biosimilars for Inflammatory Bowel Disease. Gastroenterology. 150(4). S443–S444. 9 indexed citations
6.
Goyette, Philippe, Christine Lefebvre, Aylwin Ng, et al.. (2008). Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunology. 1(2). 131–138. 62 indexed citations
7.
Panaccione, Remo, Richard N. Fedorak, Guy Aumais, et al.. (2008). Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis. SHILAP Revista de lepidopterología. 22(3). 261–272. 10 indexed citations
8.
Aumais, Guy, et al.. (2005). Pharmacokinetics and Pilot Efficacy of???a Mesalazine Rectal Gel in Distal Ulcerative Colitis. Drugs in R&D. 6(1). 41–46. 4 indexed citations
9.
Aumais, Guy, Marc Lefebvre, Claude Tremblay, et al.. (2002). Rectal tissue, plasma and urine concentrations of mesalazine after single and multiple administrations of 500 mg suppositories to healthy volunteers and ulcerative proctitis patients. Alimentary Pharmacology & Therapeutics. 17(1). 93–97. 10 indexed citations
10.
Ferraro, Pietro, Gilles Beauchamp, Daniel R. Ouellette, Claude Emond, & Guy Aumais. (1995). [Endoscopic YAG laser and palliative therapy of cancer of the esophagus].. PubMed. 49(8). 669–73. 1 indexed citations
11.
Ferraro, Pietro, Gilles Beauchamp, & Guy Aumais. (1990). Endoscopic Nd:YAG laser therapy of malignant esophageal obstruction on an outpatient basis.. PubMed. 33(6). 479–82. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026